Mental Health

According to the investigators, payers and employers are increasingly adopting HDHPs in an effort to control rising health care costs.

Pharmacy Times® interviewed Susan Van Cleve, Clinical Professor and Primary Care Pediatric Nurse Practitioner program director, University of Iowa College of Nursing, on identifying and treating anxiety in children and teens who present comorbidities.

In the United States, 3.5 million people have been diagnosed with schizophrenia and it is a leading cause of disability.

individuals with four or more depressive symptoms had a 20% increase in cardiovascular events and death.

Kimberly Erlich, MSN, RN, MPH, CPNP, PMHS, Nurse Practitioner, Pacific Coast Psychiatric Associates & the Healthy Teen Project, discusses pharmacogenomics and behavioral health in treatment of children and teens.

A new study conducted by researchers at Bar-Ilan University and the University of Haifa has linked coronavirus disease 2019 (COVID-19)-based loneliness in older adults with elevated psychiatric symptoms of anxiety, depression, and trauma symptoms that immediately follow exposure to trauma.

Dawn Lee Garzon Maaks, PhD, CPNP-PC, PMHS, FAANP, FAAN, the Immediate Past President of NAPNAP and the Associate Professor at the University of Portland in the School of Nursing, discusses caring and prescribing for children with ADHD who have other comorbidities.

Elizabeth Skoy, PharmD, and Amy Werremeyer, PharmD, BCPP, associate professors at the North Dakota State University School of Pharmacy, discuss what they feel is the value of the pharmacist.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

Elizabeth Skoy, PharmD and Amy Werremeyer, PharmD, BCPP, discuss what patients wish their pharmacists knew about mental health.

Because of continuing social distancing policies and stay-at-home orders, many families have been unable to grieve their family members at funerals or other family gatherings.

Mental health first aid trains participants to recognize risk factors and warning signs for mental health and addiction concerns.

Over the past 10 years, pediatric emergency department (ED) visits for mental health disorders have risen 60% and the rate of visits for deliberate self-harm have increased by 329%, according to a study published by Pediatrics.

More than one-third of Americans report that COVID-19 has had a serious impact on their mental health.

This new study showed for the first time that an enzyme, known as fatty acid synthase (FASN), specifically may be responsible for causing cognitive deficits.

Can donepezil be the cause of abnormal dreams?

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

Researchers examined the long-term relationship between eating foods containing flavonoids and the risk of AD and AD-related dementias (ADRD).

The findings of a recent survey from ValuePenguin found that 55% of the 1200 respondents said their mental health is suffering because of COVID-19, more specifically in millennials (63%) and parents with younger children (64%).

Emotional, social, and psychiatric problems in children and adolescents have been linked to higher levels of genetic vulnerability for adult depression.

According to the results of a nationwide survey conducted among clinical pharmacists, too many working hours is the major factor causing burnout, followed by inadequate management.

This cohort included 307 patients with schizophrenia and 364 healthy controls who were 45 years old and younger.

With all the factors of the COVID-19 outbreak taken into consideration, simply maintaining your current body weight and level of health and fitness is a win worth celebrating.

This group of health care professionals has experienced the burdens associated with increased patient demands, the potential for exposure, and shifting role expectations.

Caplyta is an oral, once daily medicine approved for the treatment of schizophrenia in adults.